BNC101 Data to be Presented at European Cancer Conference
November 20, 2014 11:12 ET
|
Bionomics Limited
ADELAIDE, Australia, Nov. 20, 2014 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO) (ADR:BMICY) is presenting a poster on cancer stem cell antibody BNC101 at the 26th EORTC-NCI-AACR Symposium on...
Bionomics to Present BNC210 at Society for Neuroscience Meeting
November 17, 2014 08:03 ET
|
Bionomics Limited
ADELAIDE, Australia, Nov. 17, 2014 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO) (ADR:BMICY) is presenting a poster on anti-anxiety compound BNC210 at the Neuroscience 2014 conference being held by...
Bionomics to Progress BNC210 in Clinical Trials
November 11, 2014 08:00 ET
|
Bionomics Limited
Bionomics to accelerate BNC210 development for the treatment of anxiety and depression, approval for clinical trial granted
Bionomics has re-acquired sole worldwide rights to develop and...
Bionomics Presents BNC105 Phase II Renal Cancer Trial Biomarker Data
September 29, 2014 07:30 ET
|
Bionomics Limited
Progression Free Survival at six months by renal cancer patients increased from 36% to 60% for a patient group defined by four biomarkers
57% of patients had the four biomarkers
ADELAIDE,...
Bionomics Acquires Prestwick Chemical
September 23, 2014 07:30 ET
|
Bionomics Limited
Pre-existing business integration and strong synergies
Valuable drug libraries and in-house expertise
Blue chip medium and large pharma customer base
High upside potential with modest...
Bionomics Receives $7.5M 2014 R&D Tax Incentive
September 05, 2014 07:30 ET
|
Bionomics Limited
ADELAIDE, South Australia, Sept. 5, 2014 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO) (ADR:BMICY) has received an Australian R&D Tax Incentive payment of $7.5 million following its FY2014 tax...
Bionomics and Merck Enter New Research Collaboration
June 23, 2014 19:03 ET
|
Bionomics Limited
*DETAILS FOR 10:30AM AEST WEBCAST BELOW*
Agreement to fund development of compounds for cognitive impairment associated with Alzheimer's disease and other conditions of the central nervous...
Bionomics Features at American Association for Cancer Research Annual Meeting
April 07, 2014 06:30 ET
|
Bionomics Limited
ADELAIDE, South Australia, April 7, 2014 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO) (ADR:BMICY) is delivering three poster presentations at the 105th Annual American Association for Cancer...
BNC105 Phase II Renal Cancer Trial Results
March 18, 2014 18:30 ET
|
Bionomics Limited
Bionomics to Host Webcast at 6:30pm ET TODAY
Results show BNC105 utility in patients with advanced disease
Identified biomarkers which correlate with patient benefit (progression free...
Bionomics Wins Awards at Major BioPharma Asia Convention
March 13, 2014 07:30 ET
|
Bionomics Limited
ADELAIDE, South Australia, March 13, 2014 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO) has been named as the Innovative Asian Biotech of the Year at this week's BioPharma Asia Industry Awards...